OBIO icon

Orchestra BioMed
OBIO

Overview Fund Activity

50 hedge funds and large institutions have $124M invested in Orchestra BioMed in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 3 closing their positions.

Holders
50
Holders Change
+4
Holders Change %
+8.7%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
12
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
DKCM
1
Davidson Kempner Capital Management
New York
$9.44M
2
M
2
Murchinson
Ontario, Canada
$3.06M
3
KPF
3
K2 Principal Fund
Ontario, Canada
$3.27M
4
GL
4
Governors Lane
New York
$2.55M
5
ASM
5
ATW SPAC Management
New York
$1.6M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$2.45M
2
LGM
2
Logos Global Management
California
$1.02M
3
SFM
3
Sphera Funds Management
Israel
$0
4
SCM
4
Suvretta Capital Management
New York
$0
5
GPCM
5
Granite Point Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SFM
51
Sphera Funds Management
Israel
– – -100,000 Closed
SCM
52
Suvretta Capital Management
New York
– – -50,000 Closed
GPCM
53
Granite Point Capital Management
Massachusetts
– – -48,000 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3